• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过重采样改进自适应临床试验中的样本量重新计算。

Improving sample size recalculation in adaptive clinical trials by resampling.

机构信息

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, 10117 Berlin, Germany.

Institute of Medical Biometry and Informatics, University Medical Center Ruprechts-Karls University Heidelberg, Heidelberg, Germany.

出版信息

Pharm Stat. 2021 Nov;20(6):1035-1050. doi: 10.1002/pst.2122. Epub 2021 Apr 1.

DOI:10.1002/pst.2122
PMID:33792167
Abstract

Sample size calculations in clinical trials need to be based on profound parameter assumptions. Wrong parameter choices may lead to too small or too high sample sizes and can have severe ethical and economical consequences. Adaptive group sequential study designs are one solution to deal with planning uncertainties. Here, the sample size can be updated during an ongoing trial based on the observed interim effect. However, the observed interim effect is a random variable and thus does not necessarily correspond to the true effect. One way of dealing with the uncertainty related to this random variable is to include resampling elements in the recalculation strategy. In this paper, we focus on clinical trials with a normally distributed endpoint. We consider resampling of the observed interim test statistic and apply this principle to several established sample size recalculation approaches. The resulting recalculation rules are smoother than the original ones and thus the variability in sample size is lower. In particular, we found that some resampling approaches mimic a group sequential design. In general, incorporating resampling of the interim test statistic in existing sample size recalculation rules results in a substantial performance improvement with respect to a recently published conditional performance score.

摘要

临床试验中的样本量计算需要基于深刻的参数假设。错误的参数选择可能导致样本量过小或过大,并可能产生严重的伦理和经济后果。适应性分组序贯研究设计是解决计划不确定性的一种方法。在这里,根据观察到的中期效果,可以在正在进行的试验中更新样本量。然而,观察到的中期效果是一个随机变量,因此不一定与真实效果相对应。处理与这个随机变量相关的不确定性的一种方法是在重新计算策略中包含重抽样元素。本文专注于具有正态分布终点的临床试验。我们考虑观察到的中期检验统计量的重抽样,并将这一原理应用于几种已建立的样本量重新计算方法。由此产生的重新计算规则比原始规则更平滑,因此样本量的变化更小。特别是,我们发现一些重抽样方法模拟了分组序贯设计。一般来说,在现有的样本量重新计算规则中纳入中期检验统计量的重抽样会导致与最近发布的条件性能得分相比,性能得到显著提高。

相似文献

1
Improving sample size recalculation in adaptive clinical trials by resampling.通过重采样改进自适应临床试验中的样本量重新计算。
Pharm Stat. 2021 Nov;20(6):1035-1050. doi: 10.1002/pst.2122. Epub 2021 Apr 1.
2
Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs.平滑校正改进适应性分组序贯研究设计中的样本量重估规则。
Methods Inf Med. 2021 May;60(1-02):1-8. doi: 10.1055/s-0040-1721727. Epub 2021 Mar 1.
3
A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.一种用于评估具有样本量重新计算的适应性成组序贯设计的新条件性能评分。
Stat Med. 2020 Jul 10;39(15):2067-2100. doi: 10.1002/sim.8534. Epub 2020 Apr 6.
4
Sample size recalculation in three-stage clinical trials and its evaluation.三阶段临床试验中的样本量重估及其评价。
BMC Med Res Methodol. 2024 Sep 25;24(1):214. doi: 10.1186/s12874-024-02337-9.
5
Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints.将条件性能评分扩展到二分类结局的样本量重估规则设定。
BMC Med Res Methodol. 2024 Jan 19;24(1):15. doi: 10.1186/s12874-024-02150-4.
6
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials.条件功效和朋友:(不)计划、(不)盲法样本量重估在确证性试验中的原因和方法。
Stat Med. 2022 Feb 28;41(5):877-890. doi: 10.1002/sim.9288. Epub 2022 Jan 13.
7
Adaptive propensity score procedure improves matching in prospective observational trials.适应性倾向评分法可改善前瞻性观察性试验中的匹配效果。
BMC Med Res Methodol. 2019 Jul 16;19(1):150. doi: 10.1186/s12874-019-0763-3.
8
The reassessment of trial perspectives from interim data--a critical view.基于中期数据对试验前景的重新评估——批判性观点。
Stat Med. 2006 Jan 15;25(1):23-36. doi: 10.1002/sim.2180.
9
Adaptive group sequential survival comparisons based on log-rank and pointwise test statistics.基于对数秩检验和逐点检验统计量的自适应分组序贯生存比较。
Stat Methods Med Res. 2021 Dec;30(12):2562-2581. doi: 10.1177/09622802211043262. Epub 2021 Oct 12.
10
Blinded sample size recalculation in adaptive enrichment designs.适应性富集设计中的盲法样本量重估。
Biom J. 2023 Feb;65(2):e2000345. doi: 10.1002/bimj.202000345. Epub 2022 Aug 19.